Cyclosporine A or Tacrolimus for Hepatitis C Recurrence? An Old Debate

摘要

Prospective studies analyzing the potential influence of cyclosporine A versus tacrolimus following liver transplant for hepatitis C virus on the new anti-viral protease and polymerase inhibitors might help address the perennial debate of the best calcineurin inhibitor for this indication. See article by Irish et al on page 1676.